Cargando…

Inclusion criteria in sepsis trials should include severity of organ dysfunction

Detalles Bibliográficos
Autores principales:	Taneja, R, Read, MS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333418/ http://dx.doi.org/10.1186/cc1298

Ejemplares similares

The impact of eligibility criteria on enrollment in ICU sepsis clinical trials
por: Foster, D, et al.
Publicado: (1999)

Correlation between changes in mediators and number of dysfunctional organs in sepsis-associated multiple organ dysfunction syndrome (MODS)
por: Taniuchi, H, et al.
Publicado: (2003)

Important factors for the modelling and design of clinical trials for severe sepsis and multiple organ failure
por: Shaikh, L, et al.
Publicado: (1999)

Monoethylglycinexylidide (MEGX) as an early predictor of liver dysfunction in severe sepsis
por: Esen, F, et al.
Publicado: (1997)

Is the degree of multiple organ dysfunction related to severity of capillary leakage?
por: Knotzer, H, et al.
Publicado: (2002)

Delayed neutrophil apoptosis in sepsis is associated with reduced Caspase-3 activity
por: Taneja, R, et al.
Publicado: (1999)

Time course of organ dysfunction comparing survivors and nonsurvivors: results of the multicentric study 'Sepsis occurrence in the acutely ill patients' (SOAP)
por: Gerlach, H, et al.
Publicado: (2003)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

Anti-nuclear antibody (ANA) analysis should include specific analysis of antibodies to SS-A/Ro
por: Dahle, C, et al.
Publicado: (2002)

Evaluation of the logistic organ dysfunction system for the assessment of organ dysfunction and mortality
por: Metnitz, PGH, et al.
Publicado: (2000)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Correlation of cytokine levels with clinical markers of organ hypoperfusion in sepsis syndrome patients (INTERSEPT trial)
por: Lemm, G, et al.
Publicado: (1997)

Severe asthma: prescribing criteria and asthma control test improvement
por: Dortas, Sérgio Duarte, et al.
Publicado: (2015)

Steroid hormone synthesis is impaired in patients with severe sepsis
por: Angstwurm, M, et al.
Publicado: (2003)

Characteristics of patients with sepsis and multiple organ failure in the UK
por: Shaikh, L, et al.
Publicado: (1999)

Prognostic value of the bone marrow in severe sepsis/septic shock
por: Milheiro, R, et al.
Publicado: (1999)

Complement activation in relation to age in patients with severe sepsis
por: Marx, G, et al.
Publicado: (2002)

The IL-10 -819T polymorphism is associated with increased susceptibility to severe sepsis
por: Wood, KA, et al.
Publicado: (2003)

Phagocytosis of granulocytes is decreased in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2000)

Case report: short time reversible myocardial dysfunction in sepsis treated with drotrecogin alpha
por: Costa-Filho, RC, et al.
Publicado: (2003)

Severe atopic eczema and recurrent infections:diagnosis of the Job syndrome according to Guimbacher criteria
por: Gomes, Luiz Carlos Bandoli
Publicado: (2015)

Nutritional parameters in patients with severe catabolism due to trauma or sepsis
por: Gallioli, G, et al.
Publicado: (1997)

Multi-organ-failure (MOF) with and without sepsis: differences in incidence and pattern of detected arrhythmias
por: Prondzinsky, R, et al.
Publicado: (1997)

Hyperdynamic circulation following cardiopulmonary bypass predisposes to postoperative bleeding
por: Taneja, R, et al.
Publicado: (2001)

Abdominal sepsis in patients 65-onwards after non-scheduled laparotomy
por: García-Saura, P, et al.
Publicado: (2000)

Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials
por: Assaad-Khalil, S
Publicado: (2003)

Sepsis: cause of late deterioration of intracranial pressure in patients with severe traumatic brain injury?
por: Dostal, P, et al.
Publicado: (1998)

An upper estimate of the attributable mortality and cost of severe sepsis in surgical patients
por: Linde-Zwirble, WT, et al.
Publicado: (2003)

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis
por: Inthorn, D, et al.
Publicado: (1998)

Comparing the effects of dopexamine and dobutamine on splanchnic parameters in patients with severe sepsis
por: Esen, F, et al.
Publicado: (1998)

Prognosis related to organ dysfunction in intensive care unit
por: Martins, PS, et al.
Publicado: (1999)

Role of multiple organ dysfunction syndrome in ARDS mortality
por: Dias, FS, et al.
Publicado: (2002)

Metabolic acidosis and organ dysfunctions in critically ill patients
por: Taniguchi, LU, et al.
Publicado: (2003)

Pathogenesis of organ damage during sepsis. In vitro influence of lipopolysaccharides and cytokines on the microtubular system
por: Ruβwurm, S, et al.
Publicado: (1997)

Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
por: Staubach, KH, et al.
Publicado: (1998)

Acidosis and mortality in severe sepsis and septic shock evaluated by base excess variation
por: Palma, LC, et al.
Publicado: (2003)

How well does TOKS identify patients with severe sepsis or septic shock?
por: Tanderup, Anette, et al.
Publicado: (2013)

Impact of socioeconomic status on mortality and morbidity in patients with severe sepsis and septic shock
por: Schnegelsberg, Amal, et al.
Publicado: (2015)

SIRS in ICU: a different approach in sepsis assessment: clinical predictivity, severity scores, costs
por: Oggioni, R, et al.
Publicado: (1997)

Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
por: Launois, R, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_tjv7dhvclgi8elnkop27o6s906